Related Experiment Video
Updated: Jan 23, 2026

Effects of Exposure of Formaldehyde to a Rat Model of Atopic Dermatitis Induced by Neonatal Capsaicin Treatment
Published on: September 27, 2017
Development of a new diaper dermatitis-like reconstructed skin equivalent for testing children atopic dermatitis
Linyi Zhuang1, Hongjian Gu1, Yu Huang1
1Pigeon Manufacturing Shanghai Co., Ltd., Shanghai, China.
Insights
A new in vitro model using reconstructed human skin effectively mimics diaper dermatitis. This model helps evaluate formulas that reduce inflammation and improve skin barrier function, offering relief for diaper rash symptoms.
Area of Science:
- Dermatology
- In vitro skin models
- Inflammatory skin conditions
Background:
- Diaper dermatitis (DD) is a prevalent inflammatory skin condition impacting children and families.
- Existing treatments focus on symptom relief, necessitating better screening methods.
- Developing reliable in vitro models is crucial for evaluating therapeutic interventions.
Purpose of the Study:
- To create and validate an in vitro reconstructed human skin equivalent for diaper dermatitis.
- To screen and assess the efficacy of different topical formulas in alleviating DD symptoms.
- To evaluate the anti-inflammatory and skin barrier repair potential of tested formulations.
Main Methods:
- A diaper dermatitis-like human skin equivalent was developed using 0.2% Sodium lauryl sulfate (SLS).
- The model exhibited key DD characteristics: elevated interleukin-1α (IL-1α) and compromised skin barrier.
- Four anti-inflammatory and barrier-promoting formulas were applied topically and assessed for IL-1α levels, tissue viability, and barrier function.
Main Results:
- SLS successfully induced inflammation, reduced tissue viability, and impaired skin barrier function in the skin equivalent.
- A cream formulation demonstrated significant efficacy in mitigating SLS-induced irritation.
- Tested cream reduced IL-1α levels and improved tissue viability compared to placebo.
Conclusions:
- The SLS-induced reconstructed human skin equivalent accurately replicates the inflammatory response seen in diaper dermatitis.
- This in vitro model serves as a valuable tool for evaluating the efficacy of diaper dermatitis treatments.
- The study highlights the potential of specific formulations in managing diaper dermatitis symptoms.
Background:
Diaper dermatitis (DD) is the most common acute inflammatory skin disease. It has a serious effect on children's and families' quality of life. We aimed to screen and evaluate the efficacy of different formulas for relieving the diaper dermatitis symptoms by developing a kind of diaper dermatitis-like reconstructed human skin equivalent in vitro.
Materials And Method:
We developed the human skin equivalent for diaper dermatitis with 0.2% Sodium lauryl sulfate (SLS). The diaper dermatitis-like human skin equivalent was characterized by high level of inflammation, such as overexpression of interleukin-1α (IL-1α), and impaired skin barrier. Four formulas with potential of anti-inflammation and promotion of skin barrier function were topically applied on the diaper dermatitis-like human skin equivalent surface. The afterward protection efficacy was evaluated by endpoints of IL-1α, tissue viability, and skin barrier function.
Results:
The chemical irritant induced high release of IL-1α, impaired tissue viability, and skin barrier function. The cream prepared with potential of anti-inflammation and skin protection could effectively decrease and relive the impact of irritant with decreased level of IL-1α and the higher tissue viability than the placebo exposure.
Conclusion:
The results showed that diaper dermatitis-like human skin equivalent induced by SLS can mimic the skin irritation response of the diaper rash.
Related Concept Videos
Pharmaceutical Equivalents
Equivalent Capacitance
The following strategies are adopted to calculate...
Equivalent Capacitance
Thévenin Equivalent Circuits
Equivalent Resistance
Principle of Equivalence

